At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 35 enrolled
Drug / intervention
curcumin +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients With Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
In Brief
A Phase 2 clinical trial evaluating curcumin, cholecalciferol, and 2 other interventions for Contiguous Stage II Small Lymphocytic Lymphoma and 5 related conditions. Completed, enrolled 35 participants across 1 site.
Detailed Summary
This phase II trial studies the efficacy (activity), and tolerability of curcumin and cholecalciferol combination in treating patients with previously untreated stage 0-II chronic lymphocytic leukemia or small lymphocytic lymphoma. Curcumin and cholecalciferol may prevent or slow the growth of cancer cells.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage I Small Lymphocytic Lymphoma, Stage II Chronic Lymphocytic Leukemia
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 2014
Enrollment StartOct 2014
Primary CompletionApr 2018
Study CompletionDec 2018
TodayJul 2026
First PostedApr 1, 2014
Enrollment StartOct 16, 2014
Primary CompletionApr 4, 2018
Study CompletionDec 13, 2018
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 12.3 years ago
Interventions
curcumindrug
Given PO
cholecalciferoldietary
Given PO
laboratory biomarker analysisother
Correlative studies
pharmacological studyother
Correlative studies